| Literature DB >> 35807405 |
Min Chen1, Shan-Shan Wen1, Rui Wang1, Qing-Xuan Ren1, Chen-Wan Guo1, Ping Li1, Wen Gao1.
Abstract
The greatest challenge in the analysis of herbal components lies in their variety and complexity. Therefore, efficient analytical tools for the separation and qualitative and quantitative analysis of multi-components are essential. In recent years, various emerging analytical techniques have offered significant support for complicated component analysis, with breakthroughs in selectivity, sensitivity, and rapid analysis. Among these techniques, supercritical fluid chromatography (SFC) has attracted much attention because of its high column efficiency and environmental protection. SFC can be used to analyze a wide range of compounds, including non-polar and polar compounds, making it a prominent analytical platform. The applicability of SFC for the separation and determination of natural products in herbal medicines is overviewed in this article. The range of applications was expanded through the selection and optimization of stationary phases and mobile phases. We also focus on the two-dimensional SFC analysis. This paper provides new insight into SFC method development for herbal medicine analysis.Entities:
Keywords: application; herbal medicines; mobile phase; multidimensional chromatography; stationary phase; supercritical fluid chromatography
Mesh:
Year: 2022 PMID: 35807405 PMCID: PMC9268462 DOI: 10.3390/molecules27134159
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Optimization of stationary phases for six standard alkaloids separation. (a) BEH, (b) BEH 2-EP, and (c) CSH PFP columns. Analytes: (1) compound 1, (2) euonymine, (3) wilfornine D, (4) wilforgine, (5) wilforine, and (6) hyponine E. Adapted from [31] with permission. Copyright 2015, Elsevier.
Figure 2Effect of the addition of an acidic additive to the mobile phase on the separation of flavonoids. Column: ZORBAX RX-SIL column (150 mm × 4.6 mm, 5 μm); mobile phase: supercritical carbon dioxide (scCO2) and MeOH containing 0.1% formic acid (FA), 0.1% acetic acid (HAc), or 0.1% phosphoric acid (H3PO4). Adapted from [61] with permission. Copyright 2017, Elsevier.
Figure 3Overview of the specific stationary phases and mobile phases that match the solute. As the polarity of the solute increases, so does the polarity of the stationary phase and mobile phase.
Application of SFC in the analysis of natural products.
| Categories | Analytes | Species (Part) | Stationary Phases | Modifier | Elution | Detector | Purpose | Ref. |
|---|---|---|---|---|---|---|---|---|
|
| 13 triacylglycerols | Soybean | three Chromolith Performance RP-18e columns (100 mm × 4.6 mm, –) | MeOH with 0.1% ( | 20 min; gradient elution | MS | Qualitative | [ |
| 32 glycerides | Torus 2-PIC (100 mm × 3.0 mm, 1.7 μm) | MeOH:ACN (9:1) | 8 min; gradient elution | MS | Qualitative | [ | ||
| 24 lipids | Torus 2-PIC (100 mm × 3.0 mm, 1.7 μm) | MeOH | 14 min; gradient elution | MS | Qualitative | [ | ||
|
| 8 carotenoids | Microalgae and rosehip | Torus 1-AA (100 mm × 3 mm, 1.7 μm) | MeOH | 7 min; gradient elution | DAD and MS | Qualitative | [ |
| 21 carotenoids |
| Ascentis Express C30 (150 mm × 4.6 mm, 2.7 μm) | MeOH | 16 min; gradient elution | MS | Qualitative | [ | |
| 31 carotenoids | Ascentis Express C30 (150 mm × 4.6 mm, 2.7 μm) | MeOH | 16 min; gradient elution | MS | Qualitative | [ | ||
| 25 apocarotenoids |
| Ascentis Express C30 (150 mm × 4.6 mm, 2.7 μm) | MeOH | 10 min; gradient elution | MS | Qualitative | [ | |
|
| 5 triterpenes | HSS C18 SB column (100 mm × 3 mm, 1.8 μm) | MeOH with 0.08% TFA | 17 min; gradient elution | ELSD | Quantitative | [ | |
| 8 triterpenoids | Apple pomace extracts | Synergi Polar-RP (250 mm × 4.6 mm, 4 μm) | MeOH | isocratic elution: 3% modifier | ELSD | Qualitative | [ | |
| 6 sesquiterpenes | ACQUITY UPC2 BEH 2-EP column (150 mm × 3 mm, 1.7 μm) | MeOH:IPA (1:1) with 0.5% FA | 15 min; gradient elution | PDA and MS | Qualitative | [ | ||
| Camphor | Acquity UPC2 BEH-2EP column (100 mm × 3 mm, 1.7 μm) | IPA | 10 min; gradient elution | DAD | Quantitative | [ | ||
| Continentalic acid and kaurenoic acid | Acquity UPC2 Torus 1-AA column (150 mm × 2.1 mm, 1.7 μm) | MeOH with 0.1% FA | isocratic elution: 3% modifier | DAD | Quantitative | [ | ||
| 18 diterpene esters |
| Hypercarb column (Carbon, 100 mm × 2.1 mm, 3 μm) | EtOH with 0.1% FA | 20 min; gradient elution | DAD and MS | Qualitative | [ | |
| 5 terpene lactones, |
| ACQUITY UPC2 BEH 2-EP column (150 mm × 3 mm, 1.7 μm) | MeOH:IPA (50:50) with 10 mM ammonium acetate | 12 min; gradient elution | PDA and MS | Quantitative | [ | |
| 12 limonoid aglycones | Citrus essential oil | Ascentis C18 column (250 mm × 4.6 mm, 5 μm) | MeOH | 20 min; gradient elution | MS | Qualitative | [ | |
| 2 triterpenoid acids | Shim-pack UC-X Diol Column (150 mm × 4.6 mm, 3 μm) | MeOH | 20 min; gradient elution | UV | Quantitative | [ | ||
|
| Triterpenoid saponins: 9 kudinosides, 6 stauntosides, and 11 ginsenosides | ZORBAX RX-SIL column (150 mm × 4.6 mm, 5 μm) | B1: MeOH with 0.05% FA and 10% H2O; | Kudinosides: 15 min; | DAD and MS | Qualitative | [ | |
| 10 furostanol saponins | Diol column (150 mm × 3 mm, 1.7 μm) | MeOH with 0.2% NH3·H2O and 3% H2O | 15 min; gradient elution | MS | Qualitative | [ | ||
| 7 ginsenosides, 6 nucleosides, | Ginseng, Korean ginseng, American ginseng | ZORBAX RX-SIL column (150 mm × 4.6 mm, 5 μm) | MeOH with 5 mM ammonium acetate | 20 min; gradient elution | DAD and MS | Qualitative | [ | |
| 6 ginsenosides | Cyanopropyl packed column (250 mm × 4.6 mm, 5 μm) | MeOH with 0.05% TFA | 18 min; gradient elution | ELSD | Qualitative | [ | ||
| Paeoniflorin, albiflorin, benzoyl paeoniflorin, oxypaeoniflorin, gallic acid, and benzoic acid | Raw, wine-baked, and vinegar-baked | Acquity UPC2 HSS C18 SB column (100 mm × 3.0 mm, 1.8 μm) | MeOH:ACN (70:30) with 0.1% phosphoric acid | 12 min; gradient elution | PDA | Quantitative | [ | |
| Six 25( | CHIRALPAK IC column (250 mm × 4.6 mm, 5 μm) couple CHIRALPAK IC column (150 mm × 4.6 mm, 5 μm) | MeOH | isocratic elution: 33% B | ELSD | Qualitative | [ | ||
|
| 9 cannabinoids | ACQUITY UPC2 BEH 2-EP column (150 mm × 3 mm, 1.7 μm) | IPA:ACN (80:20) with 1% H2O | 10 min; gradient elution | PDA and MS | Quantitative | [ | |
| 11 cannabinoids | ACQUITY UPC2 BEH 2-EP column (150 mm × 3 mm, 1.7 μm) | IPA:ACN (80:20) with 1% H2O | 10 min; gradient elution | PDA and MS | Quantitative (9); | [ | ||
| 7 cannabinoids |
| UHPC-( | MeOH | isocratic elution: 2% modifier | UVD and CD | Qualitative | [ | |
|
| 5 flavonoids |
| ZORBAX RX-SIL column (150 mm × 4.6 mm, 5 μm) | MeOH with 0.1% phosphoric acid | 20 min; gradient elution | DAD | Qualitative | [ |
| 7 flavonoids | Acquity UPC2 CSH fluorophenyl column | MeOH | 13 min; gradient elution | PDA | Qualitative | [ | ||
| 6 flavonoids | Zorbax RX-SIL column (150 mm × 2.1 mm, 5 µm) | MeOH | 11 min; gradient elution | DAD | Quantitative | [ | ||
| 6 flavonoid aglycones | / | Poroshell 120 EC-CN (100 mm × 3 mm, 2.7 μm) | MeOH with 20 mM [bmim][BF4] | isocratic elution: 8% modifier | DAD | Qualitative | [ | |
| 6 flavonoids | ACQUITY UPC2 Torus 2-PIC column (100 mm × 2.1 mm, 1.7 μm) | MeOH with 0.2% FA | 8 min; gradient elution | PDA | Quantitative | [ | ||
| 51 flavonoids, | Acquity UPC2 Torus Diol (100 mm × 3 mm, 1.7 μm) | MeOH:ACN (50:50) with 5 mM oxalic acid and 3% H2O | MS: 18 min; gradient elution; | MS; | Qualitative (51) | [ | ||
| 16 isoflavones | Acquity Torus Diol column (100 mm × 3 mm, 1.7 μm) | MeOH with 1 mM oxalic acid | 12 min; gradient elution | PDA and MS | Quantitative | [ | ||
| 9 isoflavones | Dietary supplements containing | Acquity UPC2 BEH column (100 mm × 3 mm, 1.7 μm) | MeOH with 0.05% phosphoric acid | 15 min; gradient elution | PDA | Qualitative | [ | |
| 17 flavonoids and polyphenols | Sweet potato leaf | Acquity UPC2 BEH 2-EP column (100 mm × 3 mm, 1.7 μm) | MeOH with 0.05% FA | 10 min; gradient elution | MS | Quantitative | [ | |
| 3 flavonoids, |
| ACQUITY UPC2 BEH column (100 mm × 3 mm, 1.7 µm) | MeOH | 10 min; gradient elution | PDA | Qualitative | [ | |
| Xanthohumol | Hop extracts | Waters Symmetry C18 column (250 mm × 4.6 mm, 5 μm); | EtOH | 5 min; gradient elution | DAD | Qualitative | [ | |
|
| 6 phenolics | Liquidambaris (resin) | Acquity UPC2 BEH 2-EP Column (100 mm × 3 mm, 1.7 µm) | MeOH with 0.1% phosphoric acid | 5 min; gradient elution | PDA | Quantitative | [ |
| 9 phenolic compounds |
| Shim-pack UC-X Diol column (150 mm × 4.6 mm, 3 μm) | MeOH containing 0.1 mM oxalic acid and 1 mM ammonium formate | 8 min; gradient elution | MS | Qualitative | [ | |
| 12 phenolic acids | Extra-virgin olive oil | Platisil CN column (250 mm × 4.6 mm, 5 μm) | MeOH containing 7% water and 0.5% FA | 30 min; gradient elution | DAD and MS | Quantitative | [ | |
| 7 phenolic acids | ACQUITY UPC2 BEH (100 mm × 3 mm, 1.7 μm) | MeOH:ACN (70:30) with 1% TFA | 20 min; gradient elution | PDA | Quantitative | [ | ||
| 4 polyphenols | Bee pollen sample | DCpak PBT (250 mm × 4.6 mm, 5 μm) | MeOH with 0.1% TFA | 24 min; gradient elution | PDA | Qualitative | [ | |
| 4 lignans | Shim-pack UC-X SIL column (150 mm × 2 mm, 3 μm) | MeOH | 7.5 min; gradient elution | PDA | Quantitative | [ | ||
| 9 lignans | Viridis HSS C18 SB column (100 mm × 3 mm, 1.8 μm) | MeOH | 12 min; gradient elution | PDA | Qualitative | [ | ||
| 8 vitamin E isomers | Acquity UPC2 BEH 2-EP (100 mm × 3 mm, 1.7 μm) | MeOH:IPA (1:1, | 6.2 min; gradient elution | DAD | Quantitative | [ | ||
|
| 2 oxindole alkaloids, | Agilent Rx-Sil column (50 mm × 2.1 mm, 1.8 μm) | MeOH with 10 mM ammonium acetate | 10 min; gradient elution | DAD | Qualitative | [ | |
| 71 sesquiterpene pyridine alkaloids | ACQUITY UPC2 BEH 2-EP column (50 mm × 2.1 mm, 1.7 μm) | MeOH | 10 min; gradient elution | DAD and MS | Qualitative | [ | ||
| Four 7-epimeric spiro oxindole alkaloids |
| Torus 1-AA column (100 mm × 3 mm, 1.7 μm); | Torus 1-AA column: ACN with 0.1% diethylamine; | Torus 1-AA column: isocratic elution: 22% modifier; | PDA | Qualitative | [ | |
| 6 cinchona alkaloids | Acquity UPC2 Torus DEA column (100 mm × 3 mm, 1.7 μm) | MeOH:ACN (90:10) with 0.8% diethylamine | isocratic elution: 10 min, 2.3% modifier | PDA | Quantitative | [ | ||
| 8 isoquinoline alkaloids | Inspire PFP column (250 mm × 4.6 mm, 5 μm) | MeOH with 0.2% ammonia solution and 8% H2O | isocratic elution: 20 min 25% modifier | DAD | Qualitative | [ | ||
| 10 isoquinoline alkaloids | Zorbax RX-SIL column (150 mm × 2.1 mm, 5 µm) | MeOH with 0.25% ChCl-Gly-0.5% FA-2% H2O | 26 min; gradient elution | DAD | Qualitative | [ | ||
| 5 aconitum alkaloids | Acquity UPC2 BEH 2-EP (150 mm × 2.1 mm, 1.7 μm) | 10 mM ammonium acetate in MeOH | 4 min; gradient elution | PDA and MS | Quantitative | [ | ||
|
| 9 natural aromatic acids | Grape and fruit wines | BEH-2EP column (150 mm × 3 mm, 1.7 μm) | MeOH with 0.1% TFA | 3.5 min; gradient elution | DAD | Quantitative | [ |
| 5 coumarins | Acquity UPC2 HSS C18 SB (100 mm × 3 mm, 1.8 μm) | MeOH:ACN (1:1) with 0.1% diethylamine | 7.5 min; gradient elution | PDA | Quantitative | [ | ||
| 8 coumarins | Acquity UPC2 CSH Fluoro-Phenyl (100 mm × 3 mm, 1.7 μm) | MeOH with 0.1% diethylamine | 8 min; gradient elution | PDA | Qualitative | [ | ||
| Decursinol angelate and decursin | Acquity UPC2 CSH Fluoro-Phenyl (150 mm × 2.1 mm, 1.7 μm) | EtOH | isocratic elution: 5% modifier | PDA | Quantitative | [ | ||
| 10 annonaceous acetogenins | Acquity UPC2 BEH 2-EP Column (100 mm × 2.1 mm, 1.7 μm) | EtOH | 16 min; gradient elution | MS | Qualitative | [ | ||
| Curcumin, demethoxycurcumin, and bisdemethoxycurcumin | ACQUITY UPC2 BEH column (100 mm × 3 mm, 1.7 μm) | MeOH with 10 mM oxalic acid | 6 min; gradient elution | PDA | Qualitative | [ | ||
| 5 anthraquinones | Acquity UPC2 HSS C18 SB (100 mm × 3 mm, 1.8 μm) | MeOH with 0.05% diethylamine | 10 min; gradient elution | PDA | Quantitative | [ | ||
| 6 kavalactones | Acquity UPC2 BEH-2EP column (100 mm × 3 mm, 1.7 μm) | MeOH with 0.6% diethylamine | 5.5 min; gradient elution | PDA | Quantitative | [ | ||
| 4 aromatic constituents | Cured vanilla beans | Shimpack UC-X RP column (150 mm × 4.6 mm, 3 μm) | MeOH | 17 min; gradient elution | DAD | Quantitative | [ | |
| 9 phenylamides |
| Torus DIOL (100 mm × 3 mm, 1.7 μm) | MeOH | 15 min; gradient elution | MS | Qualitative | [ | |
| ( | MeOH | 6 min; gradient elution | PDA and MS | Qualitative | [ | |||
| Seven 25 | Chiralcel OJ-H column (250 mm × 4.6 mm, 5 μm); | MeOH | Chiralcel OJ-H column: 15 min; gradient elution; | DAD | Qualitative | [ | ||
| 11 common peaks |
| Platisil NH2 (250 mm × 4.6 mm, 5 µm) | MeOH with 0.4% diethylamine and 8% H2O | 25 min; gradient elution | DAD | Qualitative | [ | |
| 34 common peaks | HSS SB C18 column (150 mm × 2.1 mm, 1.7 μm) | MeOH with 0.2% FA | 23 min; gradient elution | DAD | Qualitative | [ |
“i.d.”: internal diameter; “dp”: diameter of particles; “Ref.”: reference; “–”: not mentioned; “DAD”: diode array detector; “PDA”: photo-diode array detector; “MS”: mass spectrometry; “ELSD”: evaporative light scattering detector.
Application of SFC in series with other chromatography techniques in the analysis of natural products.
| No. | Compounds | Species | Type | 1D Column | 2D Column | Detector | Ref. |
|---|---|---|---|---|---|---|---|
| 1 | amide alkaloids |
| Offline SFC/RPLC | XAmide column (150 mm × 4.6 mm, 5 μm) | Acquity HSS T3 (100 mm × 2.1 mm, 1.8 μm) | UV | [ |
| 2 | lignans |
| Offline SFC/RPLC | XAmide column (250 mm × 20 mm, 10 μm) | Unitary C18 column (250 mm × 10 mm, 5 μm) | UV-Vis | [ |
| 3 | triterpene saponins | Offline SFC/RPLC | Atlantis HILIC column (150 mm × 4.6 mm, 5 μm) | Agilent Poroshell EC-C18 (50 mm × 3 mm, 2.7 μm) | PDA; | [ | |
| 4 | carotenoid and chlorophyll |
| Offline SFC/RPLC | Acquity HSS C18 SB column (100 mm × 3 mm, 1.8 μm) | YMC C30 column (250 mm × 4.6 mm, 3.0 μm) | ELSD; | [ |
| 5 | carotenoids |
| Online SFC × RPLC | Ascentis ES Cyano (250 mm × 1.0 mm, 5.0 μm) | Acquity BEH C18 (50 mm × 2.1 mm, 1.7 μm) | PDA-MS | [ |
| 6 | psoralens and coumarins | Lemon oil | Online SFC × RPLC | Four Princeton | Zorbax SB C18 (50 mm × 4.6 mm, 3.5 μm) | DAD | [ |
| 7 | bufadienolides | Offline RPLC/SFC | HSS T3 column (250 mm × 4.6 mm, 5 μm) | ACQUITY UPC2 HSS C18 column (100 mm × 3.0 mm, 1.8 μm) | UV; | [ | |
| 8 | / | Blackberry sage fragrant oil | Offline RPLC/SFC | Phenomenex Luna C18 (150 mm × 4.6 mm, 3 μm) | PrincetonSFC Amino column (250 mm × 4.6 mm, 10 μm) | UV | [ |
| 9 | secondary metabolites | Online NPLC × SFC | Hypersil-CN column (200 mm × 4.6 mm, 5 μm) | Merck Chromolith Flash C18 (50 mm × 4.6 mm) | UV | [ |
“i.d.”: internal diameter; “dp”: diameter of particles; “Ref.”: reference; “–”: not mentioned. “DAD”: diode array detector; “PDA”: photo-diode array detector; “MS”: mass spectrometry; “ELSD”: evaporative light scattering detector.